Cell and gene therapies are transforming how we can treat and potentially cure disease. In response to a rapidly growing pipeline and the hope these therapies offer, FasterCures convenes roundtables and discussions to bring to light the unique regulatory and access considerations posed by cell and gene therapies.
Our goals for this program include:
elevating the perspectives of patient communities in discussions related to cell and gene therapies from FDA review and approval to access;
bringing stakeholders together to identify and advance solutions to the potential informational, logistical, and emotional challenges to access; and
conducting educational convenings and workshops on issues related to cell and gene therapy development and commercialization, including manufacturing, clinical trials, and data collection, to expand understanding and share learnings.